Dr. Eric D. Kramer, MD

Dr. Kramer practices at Medical Specialists of the Palm Beaches in Atlantis, Florida.

Dr. Kramer's NPI, 1801866587, was assigned on January 25, 2006. Dr. Kramer graduated from Temple University School of Medicine in 1984. Dr. Kramer holds Florida license ME 84215.

Dr. Kramer's primary practice is Medical Specialists of the Palm Beaches, at 5401 S Congress Ave, Atlantis, FL 33462. The practice phone is (561) 642-8500.

Dr. Kramer's primary practice is Medical Specialists of the Palm Beaches in Atlantis, Florida. The medical group on file is Medical Specialists of the Palm Beaches. Dmand AI also links Dr. Kramer to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kramer practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kramer's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kramer is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kramer's licenses on file in 3 states: Florida, Pennsylvania and New Jersey.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, head injury and hereditary polyneuropathy among the conditions Dr. Kramer treats.

CMS data shows 686 Medicare services from Dr. Kramer across 6 procedure codes in 2024, for 454 Medicare patients. Medicare paid $68,593 for them. Every service was in an office.

CMS counts 454 Medicare patients who saw Dr. Kramer in 2024. The largest group is 75 to 84, with 241 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kramer's median patient age at 79, with 54% women.

In 2024, Dr. Kramer wrote 2,090 Medicare Part D claims for 482 patients. 95% of them were for generic drugs. CMS names the drug for 1,863 of them, across 35 drugs with 11 or more claims each, at $193,151 in total drug cost. In 2023, CMS named 2,001 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Kramer for performance year 2024, reported as part of a group. Dr. Kramer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Kramer. The most frequent topics are Brain Neoplasms, Bone Marrow Transplantation and Nervous System Diseases. Dr. Kramer's most frequent co-authors are Roger Packer, MD, Bruce Howard Cohen, MD and Jill P. Ginsberg, MD.

Dmand AI links Dr. Kramer to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Constipation, Signs and Symptoms, Digestive and Parkinson Disease. Enterin Inc. sponsors the most, 3.

CMS Open Payments shows 474 general payments to Dr. Kramer from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $2,336.

Dmand AI lists 2 awards for Dr. Kramer, most recently CMS Stage 1 EHR in 2013.

Dr. Kramer graduated from Temple University School of Medicine in 1984.

Dr. Kramer is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.